Together, these findings indicated that demethylation at enhancer of MCM2 was a common event in HCC patients, which was responsible for MCM2 overexpression in HCC by regulating MCM2 transcription at genome-wide. This evidence concerns the gene MCM2 and hepatocellular carcinoma.